“a favorable trend”

A favorable trend in OS was indicated and consistent results were observed across all key subgroups (Figs. 4 , 5 ).

An immunophenotypic classification that defined the top tertile of iTIL scores as the immune‐inflamed subtype produced a favorable trend in PFS for the immune‐inflamed group, whereas OS did not differ significantly (HR, 0.70; 95% CI, 0.46–1.06; p = 0.09 for PFS; HR, 1.00; 95% CI, 0.61–1.63; p = 0.99 for OS) (Figure 4B ).

[ 6 ] also demonstrates a favorable trend and exhibits much lower error compared to the other two models, yet it still holds an error of 201.83cp.

When remnant cholesterol was modeled as a categorical variable, we also observed a U-shaped association, whereas we did not observe a significantly greater or lower risk in the other three quartiles than in the lowest quartile, despite a favorable trend toward a lower risk in the third quartile [Q3: HR (95%CI): 0.67 (0.42-1.07)].

conventional DAPT strategies following PCI revealed a favorable trend for shorter DAPT durations.

5 Conclusions This prospective clinical case series suggests that the adjunctive use of advanced platelet‐rich fibrin (A‐PRF) in the surgical management of MRONJ is associated with a favorable trend toward mucosal healing; however, in the absence of a control group, definitive conclusions regarding its efficacy cannot be drawn.

Because this meta-analysis revealed an I 2 value of 0%, indicating low statistical heterogeneity among the included studies, the pooled results suggested a favorable trend toward a reduced risk of OM in patients receiving chemotherapy.

When combined aerobic and resistance training was compared with controls, previous studies have shown a significant reduction in HbA1c and a favorable trend for glycemia [71] , [72] .

After a weighted average follow-up of 23 months, novel oral anticoagulants were associated with significant reductions in the risk of stroke or systemic embolism (OR=0.81 [0.71-0.92], I 2 =23%) all cause death (OR=0.88 [0.82-0.95], I 2 =0%), in comparison to warfarin, with a favorable trend for major bleeding (OR=0.83 [0.68-1.02], I 2 =73%).

Our study also found a favorable trend but no significant difference of IV t‐PA on functional outcome in the restricted sample of sEICAS ≥ 50%, partly because of the limited sample size ( n = 124).

No difference was found with regards to central or paravalvular regurgitation, although a favorable trend was shown in the sutureless valve, indicating a correct sealing at the aortic annulus.

Among them, only three concluded that PTR did not confer an OS benefit [ 41 , 53 , 55 ], whereas 11 reported a significant OS advantage associated with PTR [ 40 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ], and the remaining two suggested a favorable trend [ 42 , 54 ].

Conclusions: The addition of CDK4/6i to ET improves iDFS and shows a favorable trend in DRFS in early-stage HR+/HER2− breast cancer, highlighting the need for longer follow-up to clarify their long-term benefit. early-stage HR+/HER2− breast cancer CDK4/6 inhibitors endocrine therapy adjuvant therapy meta-analysis invasive disease-free survival abemaciclib ribociclib palbociclib Thi

Regarding overall outcomes, the complication rate showed a favorable trend.

The presence of a family caregiver in our study was accompanied by a favorable trend in terms of readmission and mortality in the short- and medium-term and attenuated at one year of follow-up.

The camrelizumab group (HR: 0.218, 95% CI: 0.026–1.844, p = 0.162) showed a favorable trend, but the result was not statistically significant, likely due to small sample size and high censoring rate.

Both emulgels demonstrated a favorable trend in reducing inflammatory edema compared to the untreated control group.

Our finding showing a favorable trend of tDCS relative to sham in TMT performance warrants future studies on a larger cohort of MCI subjects.

Although the proportion of patients from the BRV group who entered into the open phase of the individual trials did not generally show a favorable trend compared to the placebo group, a meta-analysis of trials of adjunctive AEDs in adults with drug-resistant focal epilepsy found the responder rates to placebo virtually double between 1989 and 2009. 100 This may partially explain the unnoticeable difference between BRV and placebo groups.

7 ). While in subgroup (MI vs CLW), there was a statistically significant difference with a favorable trend in the MI technique ( P = 0.00 < 0.05) (Fig. 8 ).

47 In this study, the survival rate was not significantly different between the LS-MF and HS-MF groups, although there was a favorable trend in the HS-ER group compared with the HS-MF group, indicating the need for further studies with increased power.

3.3 ERA could not optimize the reproductive outcomes in EET cycles in patients with a history of previous failed embryo transfers At the beginning, some studies reported a favorable trend for the reproductive outcomes in ERA-guided EET cycles in patients with a history of previous failed embryo transfers.

Other items, including “I feel a sense of accomplishment when I successfully complete the course activities” and “In this course, I enjoy challenging materials that allow me to learn new things” also exhibited a favorable trend for the experimental group.

The lack of significant improvement in mortality rates due to falls in the Polish elderly population observed since 2009, despite a favorable trend in the first decade of the analysis, may be related to an increase in the dynamics of growth in the trend of the oldest people (i.e., those aged over 80), particularly noticeable in the last decade (from 6.4% to 8.5%).

Secondary Outcomes: PFS, ORR, DCR, and Serious Adverse Effects There was a favorable trend for the addition of EGFR-mAbs to the present standard chemotherapy in PFS, ORR, and DCR.